KALA BIO, INC. Peo Actually Paid Comp Amt
KALA BIO, INC. (KALA) reported Peo Actually Paid Comp Amt of -$1.01 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-09-24.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-09-24
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | -$1.01M DEF 14A · filed 2026-09-24 |
| 2024-12-31 | $1.26M DEF 14A · filed 2026-09-24 |
| 2023-12-31 | $3.75M DEF 14A · filed 2026-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |